Anti-FADD antibody [EPR4415]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(17 Publications)
Rabbit Recombinant Monoclonal FADD antibody. Suitable for IHC-P, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 17 publications.
View Alternative Names
MORT1, GIG3, FADD, FAS-associated death domain protein, FAS-associating death domain-containing protein, Growth-inhibiting gene 3 protein, Mediator of receptor induced toxicity
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-FADD antibody [EPR4415] (AB108601)
Intracellular Flow Cytometry analysis of A431 (human epidermoid carcinoma) cells labeling FADD with purified ab108601 at 1/140 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) was used as the unlabeled control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FADD antibody [EPR4415] (AB108601)
Immunohistochemical staining of paraffin-embedded Human kidney tissue using ab108601 at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-FADD antibody [EPR4415] (AB108601)
FADD was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg with 108601 at 1/120 dilution (2μg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2 : ab108601 IP in HeLa whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab108601 in HeLa whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-FADD antibody [EPR4415] (ab108601)
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Lab
Western blot - Anti-FADD antibody [EPR4415] (AB108601)
Lanes 1 - 4 : Merged signal (red and green). Green - ab108601 observed at 25 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab108601 was shown to specifically react with FADD when FADD knockout samples were used. Wild-type and FADD knockout samples were subjected to SDS-PAGE. ab108601 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FADD antibody [EPR4415] (ab108601) at 1/1000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
FADD knockout HAP1 cell lysate at 20 µg
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 23 kDa
false
- WB
Lab
Western blot - Anti-FADD antibody [EPR4415] (AB108601)
Lanes 1 - 2 : Merged signal (red and green). Green - ab108601 observed at 23 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab108601 was shown to react with FADD in wild-type HeLa cells in western blot with loss of signal observed in FADD knockout cell line ab261817 (FADD knockout cell lysate ab257261). Wild-type and FADD knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab108601 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FADD antibody [EPR4415] (ab108601) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
FADD knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human FADD knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-fadd-knockout-hela-cell-line-ab261817'>ab261817</a>)
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-FADD antibody [EPR4415] (AB108601)
All lanes:
Western blot - Anti-FADD antibody [EPR4415] (ab108601) at 1/1000 dilution
Lane 1:
A431 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
SKBR-3 cell lysate at 10 µg
Predicted band size: 23 kDa
false
Related conjugates and formulations (2)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-FADD antibody [EPR4415]
-
Anti-FADD antibody [EPR4415] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FADD is essential in apoptosis where it assists in the assembly of the death-inducing signaling complex (DISC). Upon receptor activation FADD recruits procaspase-8 or -10 to DISC promoting their autocatalytic cleavage and activation. This leads to the subsequent cascade that results in cell apoptosis. FADD also plays a role in necroptosis and is involved in the immune response regulation highlighting its multifunctional nature in cellular processes.
Pathways
FADD integrates into the apoptotic and necroptotic pathways. In the apoptotic pathway it interacts closely with Fas a death receptor to promote caspase-8 activation. Additionally in the necroptotic pathway FADD associates with RIP1 and RIP3 contributing to an alternative form of programmed cell death. These interactions underline its significant role in controlling cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
European journal of medical research 29:405 PubMed39103890
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:441 PubMed38600351
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23590 PubMed38037286
2023
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastroenterology 29:1875-1898 PubMed37032730
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasma 70:208-215 PubMed36812233
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:9325973 PubMed35965682
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of general medicine 15:4037-4052 PubMed35444456
2022
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 6:375 PubMed34728602
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 14:3969-3983 PubMed34429629
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 7:33 PubMed33597510
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com